Patents Assigned to Apollo Neuroscience, Inc.
  • Patent number: 11872351
    Abstract: Systems and methods of delivering a therapeutic session to affect a mental or an emotional state of a user include providing a wearable stimulation device having a transducer adapted to generate tactile transcutaneous vibratory output; with a user interface, obtaining data regarding an event to be experienced by the user; communicating the data regarding an event to be experienced by the user to a computer processor; with the computer processor, creating a therapeutic session parameters comprising the following steps: assigning a set of contiguous output segments for the event, and based on the event, assigning a perceived pitch of transcutaneous vibratory output and a perceived beat of transcutaneous vibratory output to each output segment; sending, from the computer processor, the therapeutic session parameters to the transducer; and generating, with the transducer, transcutaneous vibratory output for the therapeutic session based on the therapeutic session parameters.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: January 16, 2024
    Assignee: Apollo Neuroscience, Inc.
    Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi, Raymond G. Pelletier
  • Patent number: 11534571
    Abstract: Systems and methods of treating a sleep disorder of a subject include providing a therapeutic stimulation device comprising a transducer configured to emit transcutaneous vibratory output to a body part of the subject; generating physiological data with a worn sensor and providing it to a processor; providing a stimulation pattern for transcutaneous vibratory output to be emitted by the transducer comprising a perceived pitch, a perceived beat, and an intensity; causing the transducer to emit the transcutaneous vibratory output in the stimulation pattern; determining if the subject is in a pre-sleep state or a sleep state based on the physiological data; and altering the stimulation pattern based on determining the subject is in at least one of a pre-sleep state or a sleep state comprising at least one of (i) reducing a frequency of the perceived pitch, (ii) increasing an interval of the perceived beat, or (iii) reducing the intensity.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: December 27, 2022
    Assignee: Apollo Neuroscience, Inc.
    Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi, Raymond G. Pelletier
  • Patent number: 11260198
    Abstract: Systems and methods of assisting a subject to reach a target state include obtaining input of the target state of the subject; and generating a transcutaneous vibratory output to be applied to a portion of a body of the subject to assist the subject in achieving the target state, the transcutaneous vibratory output having variable parameters comprising a perceived pitch, a perceived beat, and a perceived intensity wherein the step of generating the transcutaneous vibratory output further comprises the step of modifying the variable parameters to correspond to the target state.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 1, 2022
    Assignee: Apollo Neuroscience, Inc.
    Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi, Raymond G. Pelletier
  • Patent number: 10974020
    Abstract: Systems and methods to mitigate negative effects of a drug in a treatment of a mental health condition include administering a drug to a subject in a therapy session; determining effects of the drug, the effects being counterproductive to the therapy session; and providing tactile stimulation to a subject with a stimulation device that generates transcutaneous vibratory output to be applied to a portion of a body of the subject during the therapy session, wherein the transcutaneous vibratory output is selected to reduce the counterproductive effects of the drug.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: April 13, 2021
    Assignee: Apollo Neuroscience, Inc.
    Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi
  • Patent number: D910862
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: February 16, 2021
    Assignee: Apollo Neuroscience, Inc.
    Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi, Raymond G. Pelletier, John Joseph Maholtz, Doug Zatezalo, Gregoire B. Aby-Eva, Elijah M. Wiegmann